Page last updated: 2024-09-02
exp3174 and curcumin
exp3174 has been researched along with curcumin in 1 studies
Compound Research Comparison
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (curcumin) | Trials (curcumin) | Recent Studies (post-2010) (curcumin) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 16,336 | 593 | 12,705 |
Protein Interaction Comparison
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Du, FY; Liu, AC; Liu, T; Lou, HX; Xing, J; Zhao, LX | 1 |
Other Studies
1 other study(ies) available for exp3174 and curcumin
| Article | Year |
|---|---|
Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antioxidants; Area Under Curve; Chromatography, High Pressure Liquid; Curcumin; Female; Imidazoles; Losartan; Male; Rats; Rats, Wistar; Tandem Mass Spectrometry; Tetrazoles | 2012 |